GAMMA Investing’s Cellectis CLLS Stock Holding History

GAMMA Investing’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-463	Closed	-$1.39K	–	4342
2026 Q2	$1.39K	Sell	463 -271	-37%	-$963	﹤0.01%	3802
2026 Q1	$2.33K	Sell	734 -373	-34%	-$1.43K	﹤0.01%	3624
2025 Q4	$5.36K	Buy	+1,107	New	+$4.63K	﹤0.01%	3246

GAMMA Investing's CLLS Position: Q3 2026 in Review

GAMMA Investing sold out of Cellectis (CLLS) in Q3 2026, closing a stake of 463 shares — an estimated $1.39K sold.

GAMMA Investing first reported a position in CLLS in Q4 2025 and held it in 3 quarters. The position peaked at $5.36K in Q4 2025. 0 funds tracked by Wall St. Rank hold CLLS as of Q3 2026.

GAMMA Investing reported no remaining Cellectis position as of Q3 2026 after selling out during the quarter.
GAMMA Investing sold 463 Cellectis shares in Q3 2026, an estimated $1.39K.
GAMMA Investing first reported a position in Cellectis in Q4 2025 and held it in 3 quarters.
GAMMA Investing's Cellectis position peaked at $5.36K in Q4 2025.
0 funds tracked by Wall St. Rank held Cellectis as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.